Antisense Therapeutics Health Care
Biotech Healthcare Pharmaceuticals

$0.059 -0.003 (-4.84%)

High $0.06	Low $0.06	Trades 100	Turnover $254,071	Volume 4,352,698
30 June 2023 at 4:10pm

Market Cap (7-Mar) TBC	Close (30-Jun) $0.059 0 (0%)	Volume (30-Jun) 4,352,698	Shortsold (24-Jul) 256 (0.00%) (719th)
52w High $0.000	52w Low $0.000	P/E -	EPS -

Short Interest

ASIC data, 24 Jul 2023

% Shorted

0.00% 0.07

vs 0.07% prior report

Most Shorted Rank

719th

of 709 shorted ASX stocks

Peak Short

0.35%

Sep 2013

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	ANP ANP Ann: Proposed issue of securities - ANP
	1 (current) 2 3
	ANP ANP Ann: Positive PDCO opinion and A$20m Placement
	ANP ANP Ann: 2021 Annual Report
	ANP ANP Ann: Appendix 4G and Corporate Governance Statement
	ANP ANP Ann: Quarterly Report and Appendix 4C
	ANP ANP Ann: Trading Halt
	ANP ANP Ann: Initial Director's Interest Notice
	ANP ANP Ann: Antisense Therapeutics appoints new Non-Executive Director
	ANP ANP Ann: Positive feedback received on Paediatric Investigation Plan
	ANP ANP Ann: New data supports ATL1102s broader clinical potential
	ANP ANP Ann: ANP to present new proteomics data at WMS Congress 2021
	ANP ANP Ann: Appendix 4E and Full Year Statutory Accounts
	ANP ANP Ann: ANP to participate in development of DMD Guidance for FDA
	ANP ANP Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
	ANP ANP Ann: Quarterly Report and Appendix 4C
	ANP ANP Ann: Antisense Therapeutics transitions to new Board Chair
	ANP ANP Ann: ANP and MCRI new R&D collaboration for ATL1102
	ANP ANP Ann: ATL1102 for DMD EMA PIP feedback and FDA regulatory progress
	ANP ANP Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
	ANP ANP Ann: Manufacture of ATL1102 clinical supplies for Phase IIb trial
	ANP ANP Ann: Appendix 2A & Cleansing Notice
	ANP ANP Ann: Proposed issue of Securities - ANP
	ANP ANP Ann: Quarterly Report and Appendix 4C
	ANP ANP Ann: US FDA Type C Meeting for ATL1102 in DMD
	ANP ANP Ann: Initial Director's Interest Notice - CG
	ANP ANP Ann: Antisense Therapeutics appoints new Non-Executive Director
	ANP ANP Ann: Appendix 3G
	ANP ANP Ann: FDA Rare Disease Day 2021
	ANP ANP Ann: Jett Foundation 4th Annual Rare Disease Day
	ANP ANP Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA
	ANP ANP Ann: Company Secretary Appointment
	ANP ANP Ann: Half Yearly Report and Half Year Accounts
	ANP ANP Ann: ANP meeting with US FDA granted for ATL1102 in DMD
	ANP ANP Ann: Quarterly Update and Appendix 4C
	ANP ANP Ann: Appendix 2A
	ANP ANP Ann: Proposed issue of Securities - ANP
	ANP ANP Ann: Change of Registered Office and Principal Place of Business
	ANP ANP Ann: Ceasing to be a substantial holder
	ANP ANP Ann: Results of Annual General Meeting
	ANP ANP Ann: Annual General Meeting Chairman's Address
	ANP ANP Ann: 2020 Annual General Meeting Presentation
	ANP ANP Ann: EC grants Orphan Drug Designation for ATL1102 in DMD
	ANP ANP Ann: Receipt of R&D Tax Incentive payment
	ANP ANP Ann: Ceasing to be a substantial holder
	ANP ANP Ann: Change of Director's Interest Notice (x 2)
	ANP ANP Ann: Appendix 2A and 708A notice
	ANP ANP Ann: ANP to present at Several Upcoming Virtual Conferences
	ANP ANP Ann: Antisense Therapeutics closes SPP oversubscribed
	ANP ANP Ann: Antisense Therapeutics to present at Australian Equities Day
	ANP ANP Ann: Reminder - Antisense Therapeutics SPP Closing Date

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
06-Mar	$0.08	699,685	+0.00 (1.20%)
05-Mar	$0.08	284,901	0.00 (2.35%)
04-Mar	$0.09	569,939	0.00 (3.41%)
01-Mar	$0.09	2,253,232	+0.00 (1.15%)
29-Feb	$0.09	1,694,862	+0.01 (7.41%)
28-Feb	$0.08	5,442,601	+0.01 (10.96%)
27-Feb	$0.07	543,657	+0.00 (4.29%)
26-Feb	$0.07	410,931	0.00 (1.41%)
23-Feb	$0.07	124,523	+0.00 (2.90%)
22-Feb	$0.07	291,500	0.00 (1.43%)
21-Feb	$0.07	679,656	+0.00 (1.45%)
20-Feb	$0.07	140,000	0.00 (1.43%)
19-Feb	$0.07	332,887	0.00 (2.78%)
16-Feb	$0.07	383,238	+0.00 (1.41%)
15-Feb	$0.07	442,144	+0.00 (1.43%)
9 up, 6 down, and 0 flat days

Antisense Therapeutics Health Care
Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Antisense Therapeutics Health Care Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Antisense Therapeutics Health Care
Biotech Healthcare Pharmaceuticals